Richardson A E, James K W, Spittle C R, Robinson O P
Postgrad Med J. 1968 Nov;44(517):844-7. doi: 10.1136/pgmj.44.517.844.
Experiences in the use of carbenicillin, a new penicillin active against and other Gram-negative bacteria in the treatment of septicaemia and meningitis are described. Blood levels of carbenicillin in excess of the levels required to inhibit the infecting organisms were obtained using intravenous infusions of large doses together with probenecid by mouth. High cerebrospinal fluid levels of carbenicillin were ensured in the meningitis patients with daily intrathecal or intraventricular injections. Carbenicillin undoubtedly controlled the course of septicaemia in two patients. Rapid sterilization of the cerebrospinal fluid was achieved in both meningitis patients with clinical improvement. No evidence of toxicity was seen and daily intrathecal injections were well tolerated.
本文描述了使用羧苄青霉素(一种对[具体细菌名称]及其他革兰氏阴性菌有效的新型青霉素)治疗败血症和脑膜炎的经验。通过静脉大剂量输注并口服丙磺舒,使血液中的羧苄青霉素水平超过抑制感染菌所需的水平。对于脑膜炎患者,通过每日鞘内或脑室内注射确保脑脊液中羧苄青霉素达到高浓度。羧苄青霉素无疑控制了两名患者的败血症病程。两名脑膜炎患者的脑脊液迅速除菌,临床症状改善。未观察到毒性迹象,每日鞘内注射耐受性良好。